Associated Papers
Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review.
Wen Y et al.
Frontiers in Oncology, 2023
37920159 (PubMed )
Supplement: DataSheet_1.pdf
Select a paper to view details